Adenosine suppresses the response of neurons to gaba in the superficial laminae of the rat spinal dorsal horn

Neuroscience. 2003;119(1):145-54. doi: 10.1016/s0306-4522(03)00074-5.

Abstract

With the nystatin-perforated whole-cell patch-clamp recording technique, the modulatory effects of adenosine on GABA-activated whole-cell currents were investigated in neurons acutely dissociated from the superficial laminae (laminae I and II) of the rat spinal dorsal horn. The results showed that: (1) GABA acted on GABA(A) receptor and elicited inward Cl(-) currents (I(GABA)) at a holding potential (V(H)) of -40 mV; (2) adenosine suppressed GABA-induced Cl(-) current with affecting neither the reversal potential of I(GABA) nor the apparent affinity of GABA to its receptor; (3) N6-cyclo-hexyladenosine, a selective A(1) adenosine receptor agonist, mimicked the suppressing effect of adenosine on I(GABA), whereas 8-cyclopentyl-1,3-dipropylxanthine, a selective A(1) adenosine receptor antagonist, blocked the suppressing effect of adenosine; (4) chelerythrine, an inhibitor of protein kinase C, reduced the suppressing effect of adenosine on I(GABA); (5) pretreatment with 1,2-bis-(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis (acetoxy-methyl) ester, a Ca(2+) chelator, did not affect adenosine-induced suppression of I(GABA). The results indicate that: (1) the suppression of adenosine on I(GABA) is mediated by adenosine A(1) receptor and through a Ca(2+)-independent protein kinase C transduction pathway; (2) the interactions between adenosine and GABA might be involved in the modulation of nociceptive information transmission at spinal cord level.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / agonists
  • Adenosine / analogs & derivatives
  • Adenosine / antagonists & inhibitors
  • Adenosine / pharmacology*
  • Alkaloids
  • Analgesics / pharmacology*
  • Animals
  • Animals, Newborn
  • Benzophenanthridines
  • Bicuculline / pharmacology
  • Chelating Agents / pharmacology
  • Diglycerides / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Egtazic Acid / analogs & derivatives*
  • Egtazic Acid / pharmacology
  • Electric Conductivity
  • Enzyme Inhibitors / pharmacology
  • GABA Agonists / pharmacology
  • GABA Antagonists / pharmacology
  • Isoquinolines / pharmacology
  • Lithium / pharmacology
  • Membrane Potentials / drug effects
  • Muscimol / pharmacology
  • Neural Inhibition / drug effects
  • Patch-Clamp Techniques / methods
  • Phenanthridines / pharmacology
  • Posterior Horn Cells / drug effects*
  • Posterior Horn Cells / physiology
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord / cytology
  • Spinal Cord / drug effects
  • Spinal Cord / physiology
  • Sulfonamides*
  • Xanthines / pharmacology
  • gamma-Aminobutyric Acid / pharmacology*

Substances

  • Alkaloids
  • Analgesics
  • Benzophenanthridines
  • Chelating Agents
  • Diglycerides
  • Enzyme Inhibitors
  • GABA Agonists
  • GABA Antagonists
  • Isoquinolines
  • Phenanthridines
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Sulfonamides
  • Xanthines
  • Muscimol
  • Egtazic Acid
  • gamma-Aminobutyric Acid
  • 1-oleoyl-2-acetylglycerol
  • Lithium
  • 1,3-dipropyl-8-cyclopentylxanthine
  • chelerythrine
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Adenosine
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • Bicuculline